FDA updates labeling for ORILISSA FDA Approval Dec. 31, 2025, 13:45 UTC Labeling changes approved for ABBVIE. Active ingredient: ELAGOLIX SODIUM. Decision date: 12/17/2025 Full text
There are no comments here yet...